Xtant Medical

INVESTORS

HomeInvestors

INVESTORS

Click here for Webcast
Jefferies London Healthcare Conference Presentation
 11/16/23  6:00 AM EST

Corporate Profile

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

 

 

 

Stock Quote

(Common Stock)
Price
Change (%)
Volume
Data as of  

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart

Recent News

Date Title  
Toggle Summary Xtant Medical to Participate in Upcoming Investor Conferences
BELGRADE, Mont. , Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that management will participate in two upcoming investor conferences:
Toggle Summary Xtant Medical Announces Record Third Quarter Revenue of $25 Million
Raises 2023 Annual Revenue Guidance to $88 Million - $91 Million BELGRADE, Mont. , Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial
Toggle Summary Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023
BELGRADE, Mont. , Nov. 02, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended
Toggle Summary Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical
Expands Xtant’s Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont. , Oct. 23, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced
More
Upcoming Events
There are currently no events scheduled.
More

Receive Email Alerts

Sign up to receive email alerts whenever Xtant Medical Holdings Inc posts new information to the site. Just enter your email address and click Submit.